IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
Daniela S. Daniela Sanchez Bassères(UNC Lineberger Comprehensive Cancer Center), Albert S. Baldwin(University of North Carolina at Chapel Hill)
Cited by 35
Related Papers
Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II
|Journal of Biological Chemistry|2000|449
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
|Genes & Development|1998|402
NF-κB and IKK as therapeutic targets in cancer
|Cell Death and Differentiation|2006|393
Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression
|The EMBO Journal|2005|234